Aom-0925

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug NameAom-0925

Drug Alias NameDPP IV inhibitor (Hangzhou Adamerck Pharmlabs)dipeptidyl peptidase IV inhibitor (Hangzhou Adamerck Pharmlabs)DPP4 inhibitor (Hangzhou Adamerck Pharmlabs)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDipeptidyl peptidase IV inhibitors

TargetsDipeptidyl peptidase IV

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesHangzhou Adamerck Pharmlabs Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHangzhou Adamerck Pharmlabs Inc

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A